Brazil is the largest pharmaceutical market in Central/Southern America and among top 10 pharma market in the world and the value is around USD 32 Bn. Their healthcare expenditure is about 13% of GDP.
Brazil import around USD 11.20 Bn among the top 20 pharmaceutical products importer in the world. Brazil imports Pharmaceutical products primarily from: USA, China, Switzerland, Belgium, and Germany. China, India, and Ireland are the main suppliers of API’s to Brazil.
The Medical Devices market size approx. USD 11.9 Bn, with CAGR of 6.9% while Brazil import of medical devices is approx. USD 6.2 Bn.
Brazilian market dominated by regional and domestic/national companies which lead the business and rank highly on the list of producers. Multinationals have chosen to acquire local companies as a strategy to enter the Brazilian market.
Leading Pharmaceutical Companies in Brazil
- Aché Laboratorios Farmaceuticos SA
- Cristalia Produtos Quimicos Farmaceuticos Ltda (Cristália)
- EMS Sigma
- Eurofarma
- GlaxoSmithKline
- Medley Indústria Farmacêutica Ltda
- Merck & Co. Inc. (MSD)
- Novartis
- Pfizer
- Roche
- Sanofi SA
- NEO Quimica
- Mantecorp Farmasa
- Libbs
- Biolab-Sanus Farma
- Takeda
- Libbs Farmaceutica
- Teuto
- União Farmacêutica and Vall
Top 10 Pharmacy Chain in Brazil
- Raia Drogasil - São Paulo
- Pague Menos - Ceará
- Drogaria São Paulo - São Paulo
- Pacheco - Rio de Janeiro
- Wal-Mart - São Paulo
- Panvel - Rio Grande do Sul
- Nissei - Paraná
- Mais Econômica - Rio Grande do Sul
- Big Ben - Pará
- Imifarma - Pará
The most commonly prescribed drugs are for the treatment of chronic diseases like – Blood pressure, Diabetes, Cardiovascular, Lower Respiratory Tract Infections, COPD, Obesity with high demand of Contraceptives, Rare Diseases, Generic Drugs and Infectious Diseases – HIV and Hepatitis C.
Major Challenges of Brazil Pharma Market
- Distribution Network lies in the hands of a few national and regional groups Aggressive discount on specially on generic products.
- Brazil requirements are relatively stringent compared to those of other Latin American countries. A drug approved in USA or EU is does not guarantee its approval in Brazil.
Read also:
Resource Person: Dr. Palak Gupta
